Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inspire 2: CYT107 in HIV
NCT01190111Phase 2Terminated
- Sponsor
- Cytheris SA
- Start
- Jan 2010
- Primary completion
- Jun 2013
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of efineptakin alfa in human immunodeficiency virus infection (HIV), sponsored by Cytheris SA. Started Jan 2010; status: terminated.
02
Drugs
efineptakin alfa
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01190111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190111.